A P r e l i m i n a r y S t u d y Z.M. Wong(l), F . W . T e a r e ( l ) , B.M. Bowen(l,2), S.K. Liao(3). C.S. Kwok(41, P.C. Kvong(3), and I. B o x e n ( 5 ) ( 1 ) U n i v e r s i t y of T o r o n t o , F a c u l t y o f P h a r m a c y , 19 R u s s e l l S t r e e t , T o r o n t o , O n t a r i o ,
Development of 3-iodophenylisothiocyanate for radioiodination of monoclonal antibodies
β Scribed by Siya Ram; Donald J. Buchsbaum
- Publisher
- Elsevier Science
- Year
- 1992
- Weight
- 321 KB
- Volume
- 43
- Category
- Article
- ISSN
- 0883-2889
No coin nor oath required. For personal study only.
β¦ Synopsis
A new radioiodination reagent, 3-iodophenylisothiocyanate (3-IPI) has been developed for coupling to monoclonal antibodies. The starting material, 3-tri-n-butylstannylphenylisothiocyanate was prepared via a reaction of hexabutylditin with 3-bromoaniline, followed by treatment with thiophosgene with an overall yield of 72%. The radioiodination of this tin precursor with Na[125I]I/iodogen in chloroform gave 3-[125I]IPI in 23-55% radiochemical yield and 81-99.6% radiochemical purity. Purification of the impure product by high pressure liquid chromatography increased the radiochemical purity of the product up to 99%. These results suggest that 3-IPI may be a useful ligand for radioiodination and coupling to a variety of monoclonal antibodies.
π SIMILAR VOLUMES
## Abstract Ten arylβcarbohydrate ligands have been synthesized that potentially increase the tumor retention and decrease the deiodination of iodinated monoclonal antibodies used in the imaging and treatment of cancer. The compounds were synthesized via reductive amination reactions, purified with
## Abstract Monoclonal antibody was purified from tissue culture fluid using ceramic fluoroapatite chromatography. Efficiency of the capture step was shown to be sensitive to pH and phosphate concentration. More than 90% of host cell proteins were removed by ceramic fluoroapatite chromatography. St
n 3 Nitrate 2 hre 5.21 \* 0.065 9.87 \* 0.82 37.4 \* 8.83 9.36 0.47 1.47 \* 0.06 78 24 hre 7.7 2 1.5 6.0 \_+ 0.5 27.6 \_+ 1.0 12.1 \_+ 0.7 0.4 \_+ 0.15 58 48 hre 1.8 \* 0.32 3.34 \* 0.73 15.2 \* 1.69 13.3 \* 1.05 0.44 \* 0.21 61 -11 3-DTPAC 3 hr 1.09 \* 0.04 1.24 \* 0.11 5.46 \* 0.26 1.00 \* 0.06 -7
The biologic response to surgical implants is of importance in understanding the host interactions relating to long-term patency of implants. The methodology currently available for the assessment of host-biomaterial interactions is subjective and is limited to identification of inflammatory respons